A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients
{{output}}
Liver hepatocellular carcinoma (LIHC) comprises most cases of liver cancer with a poor prognosis. N6 -methyladenosine (m6A) plays important biological functions in cancers. Thus, the present research was aimed to determine biomarkers of m6A regulators that cou... ...
